Quoin Pharmaceuticals, Ltd. (QNRX)

Quoin Pharmaceuticals Statistics

Total Valuation

QNRX has a market cap or net worth of $6.57 million. The enterprise value is -$660,099.

Market Cap	6.57M
Enterprise Value	-660,099

Important Dates

The next estimated earnings date is Wednesday, March 12, 2025, after market close.

Earnings Date	Mar 12, 2025
Ex-Dividend Date	n/a

Share Statistics

QNRX has 20.59 million shares outstanding. The number of shares has increased by 336.80% in one year.

Current Share Class	n/a
Shares Outstanding	20.59M
Shares Change (YoY)	+336.80%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	6.00%
Owned by Institutions (%)	9.48%
Float	19.35M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.30
P/TBV Ratio	1.33
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.02, with a Debt / Equity ratio of 0.56.

Current Ratio	3.02
Quick Ratio	2.97
Debt / Equity	0.56
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -135.37% and return on invested capital (ROIC) is -59.56%.

Return on Equity (ROE)	-135.37%
Return on Assets (ROA)	-44.13%
Return on Invested Capital (ROIC)	-59.56%
Return on Capital Employed (ROCE)	-118.01%
Revenue Per Employee	n/a
Profits Per Employee	-$2.18M
Employee Count	4
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -88.68% in the last 52 weeks. The beta is 1.62, so QNRX's price volatility has been higher than the market average.

Beta (5Y)	1.62
52-Week Price Change	-88.68%
50-Day Moving Average	0.50
200-Day Moving Average	0.61
Relative Strength Index (RSI)	38.37
Average Volume (20 Days)	4,108,443

Short Selling Information

Short Interest	52,821
Short Previous Month	410,402
Short % of Shares Out	0.26%
Short % of Float	0.27%
Short Ratio (days to cover)	0.01

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-9.34M
Pretax Income	-8.28M
Net Income	-8.70M
EBITDA	-9.24M
EBIT	-9.34M
Earnings Per Share (EPS)	-$2.64

Balance Sheet

The company has $10.31 million in cash and $3.07 million in debt, giving a net cash position of $7.23 million or $0.35 per share.

Cash & Cash Equivalents	10.31M
Total Debt	3.07M
Net Cash	7.23M
Net Cash Per Share	$0.35
Equity (Book Value)	5.44M
Book Value Per Share	1.08
Working Capital	7.02M

Cash Flow

Operating Cash Flow	-8.84M
Capital Expenditures	n/a
Free Cash Flow	-8.84M
FCF Per Share	-$0.43

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

QNRX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-336.80%
Shareholder Yield	-336.80%
Earnings Yield	-132.37%
FCF Yield	-134.56%

Analyst Forecast

The average price target for QNRX is $4.00, which is 1,152.74% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$4.00
Price Target Difference	1,152.74%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Splits

The last stock split was on July 18, 2023. It was a reverse split with a ratio of 0.0833333:1.

Last Split Date	Jul 18, 2023
Split Type	Reverse
Split Ratio	0.0833333:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	1